
    
      This was a randomised, controlled, clinical trial on patients who received a primary knee
      prosthesis in 2018-2019. Treatment group was given a multi-layer foam dressing with Safetac.
      The control group received standard treatment with povidone-iodine and a gauze dressing with
      plaster. 50 patients was needed for sufficient power. Primary outcome measures were; the
      characteristics of the surgical wound, patient reported comfort and adaptability according to
      the physiotherapist. Secondary outcome measures were: the clinical status and quality of life
      level according to the Western Ontario and McMaster Universities Osteoarthritis Index
      (WOMAC). Statistical analysis was performed by using IBM SPSS version 25, with a statistical
      significance of 5%.
    
  